https://orcid.org/0000-0002-5622-0008
Overview
A. Non-small cell lung cancer
1. Evaluation of serum and tissue molecular biologic markers of recurrence in patients with a localize non-small cell lung cancer.
2. Molecular biologic staging of lymph nodes in patients with non-small cell lung cancer.
3. The evaluation of the clonality of metastatic tumors in patients with non-small cell lung cancer.
B. Clinical research activities
1. Creation of a prospective database for the Duke Thoracic Oncology Program.
2. A cost and satisfaction evaluation of thoracoscopy and open thoracotomy in patients.
3. Development of risk associated models of morbidity in patients undergoing general thoracic surgery procedures: The VA Cooperative Surgical Risk Study
4. A member of the Duke Gastrointestinal Malignancy Research Committee, developing esophageal cancer treatment protocols and outcome studies.
1. Evaluation of serum and tissue molecular biologic markers of recurrence in patients with a localize non-small cell lung cancer.
2. Molecular biologic staging of lymph nodes in patients with non-small cell lung cancer.
3. The evaluation of the clonality of metastatic tumors in patients with non-small cell lung cancer.
B. Clinical research activities
1. Creation of a prospective database for the Duke Thoracic Oncology Program.
2. A cost and satisfaction evaluation of thoracoscopy and open thoracotomy in patients.
3. Development of risk associated models of morbidity in patients undergoing general thoracic surgery procedures: The VA Cooperative Surgical Risk Study
4. A member of the Duke Gastrointestinal Malignancy Research Committee, developing esophageal cancer treatment protocols and outcome studies.
Current Appointments & Affiliations
George Barth Geller Distinguished Professor for Research in Cancer
·
2022 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Professor of Surgery
·
2003 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Professor in Pathology
·
2018 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
1987 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.
Conference J Thorac Cardiovasc Surg · January 2026 BACKGROUND: Five-year disease recurrence rates for patients with stage I non-small cell lung cancer (NSCLC) postsurgery are variable (15%-40%). There is an urgent need for novel biomarker strategies to identify high-risk patients who may benefit from adjuv ... Full text Link to item CitePatient recruitment in cardiothoracic surgery translational research
Chapter · January 1, 2026 Patient recruitment is an important aspect of translational research in all types of studies including retrospective, prospective, and clinical trials. Challenges may include obtaining patient consent, recruiting special populations, and optimizing the rec ... Full text CiteResponse to Letter to the Editor.
Journal Article J Thorac Oncol · December 2025 Full text Link to item CiteRecent Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2029Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Cancer Institute · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028View All Grants
Education
University of Virginia ·
1984
M.D.